Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Diclofenac sodium; Misoprostol
Pfizer Ltd
M01AB55
Diclofenac sodium; Misoprostol
75mg ; 200microgram
Gastro-resistant tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 10010100; GTIN: 5012882007607
Page 1 of 7 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT ARTHROTEC ® 75 MODIFIED-RELEASE TABLETS diclofenac sodium, misoprostol READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. KEEP THIS LEAFLET. YOU MAY NEED TO READ IT AGAIN. IF YOU HAVE ANY FURTHER QUESTIONS, ASK YOUR DOCTOR OR PHARMACIST. THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU ONLY. DO NOT PASS IT ON TO OTHERS. IT MAY HARM THEM, EVEN IF THEIR SIGNS OF ILLNESS ARE THE SAME AS YOURS. IF YOU GET ANY SIDE EFFECTS, TALK TO YOUR DOCTOR OR PHARMACIST. THIS INCLUDES ANY POSSIBLE SIDE EFFECTS NOT LISTED IN THIS LEAFLET. SEE SECTION 4. WHAT IS IN THIS LEAFLET 1. WHAT ARTHROTEC IS AND WHAT IT IS USED FOR 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ARTHROTEC 3. HOW TO TAKE ARTHROTEC 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE ARTHROTEC 6. CONTENTS OF THE PACK AND OTHER INFORMATION 1. WHAT ARTHROTEC IS AND WHAT IT IS USED FOR Arthrotec helps to relieve the pain and swelling of RHEUMATOID ARTHRITIS and OSTEOARTHRITIS, and may help to protect patients at risk of irritation or ulceration of the stomach or intestines. Arthrotec contains diclofenac and misoprostol. Diclofenac belongs to a group of medicinal products called Non-Steroidal Anti-Inflammatory drugs (NSAIDs). Although NSAIDs relieve the pain, they can reduce the amount of natural protective substances called prostaglandins in the stomach lining. This means that NSAIDs can lead to stomach upsets or stomach ulcers. Arthrotec also contains misoprostol which is very similar to these prostaglandins and may help protect your stomach. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ARTHROTEC DO NOT TAKE ARTHROTEC IF YOU: have had an allergic reaction such as a skin rash, swelling or itchiness of the skin, severe nasal congestion, asthma or wheezing after taking diclofenac or other NSAIDs such as aspirin (acetylsalicylic acid), misoprostol or another prostaglandin medicine, or any of the other ingredients in Arthrotec (see section 6) cu Read the complete document
OBJECT 1 ARTHROTEC 75 TABLETS Summary of Product Characteristics Updated 05-Apr-2017 | Pfizer Limited 1. Name of the medicinal product Arthrotec 75 modified-release tablets 2. Qualitative and quantitative composition Each tablet consists of a gastro-resistant core containing 75 mg diclofenac sodium surrounded by an outer mantle containing 200 micrograms misoprostol. Excipient(s) with known effect: Each tablet contains 19.5 mg lactose monohydrate. For the full list of excipients, see section 6.1. 3. Pharmaceutical form Modified-release tablet. White, round, biconvex tablets marked 'SEARLE' over '1421' on one side, and four times 'A' around the circumference with '75' in the centre on the reverse side. 4. Clinical particulars 4.1 Therapeutic indications Arthrotec 75 is indicated for patients who require the non-steroidal anti-inflammatory drug diclofenac together with misoprostol. The diclofenac component of Arthrotec 75 is indicated for the symptomatic treatment of osteoarthritis and rheumatoid arthritis. The misoprostol component of Arthrotec 75 is indicated for patients with a special need for the prophylaxis of NSAID-induced gastric and duodenal ulceration. 4.2 Posology and method of administration Posology Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4 Special warnings and precautions for use). Adults One tablet to be taken with food, two times daily. Tablets should be swallowed whole, not chewed. _Elderly/renal, cardiac and hepatic impairment_ No adjustment of dosage is necessary in the elderly or in patients with hepatic impairment or mild to moderate renal impairment as pharmacokinetics are not altered to any clinically relevant extent. Nevertheless, elderly patients and patients with renal, cardiac or hepatic impairment should be closely monitored (see section 4.4 and section 4.8). _Paediatric population_ The safety and efficacy of Arthrotec 75 in children under 18 years has not been established. 4.3 Contraind Read the complete document